Call your doctor before leaving home if you think you’ve been exposed to COVID-19 or have symptoms

Due to the presence of COVID-19 in our community, visitor restrictions are in place for all Duke clinics and hospitals. For your safety and the safety of others, we recommend patients do not bring a visitor to Duke clinics, if at all possible. If a visitor must accompany a patient, only one individual over 12 years of age is allowed. Patients and visitors will be screened for symptoms upon arrival. Individuals with flu-like symptoms are not allowed. View the complete list of Visitor Restrictions.

Effective immediately, Duke Health is prioritizing and rescheduling some non-emergent or non-critical surgeries, procedures, and appointments. Check our COVID-19 (Coronavirus) page for updates.

DJ19- Clostridium Difficile Vaccine for Older Adults - Clinical Trial

What is the Purpose of this Study?

We are doing this study to find out if a study vaccine prevents severe diarrhea caused by a germ called Clostridium Difficile (C Diff).
What is the Condition Being Studied?
C. Diff vaccine for older adults

Who Can Participate in the Study?

Adults over 50 who have with an increased risk of future contact with healthcare systems, for example:
- Have gotten antibiotics in the past 12 weeks
- Have made at least 10 outpatient medical visits in the past year
- Have been hospitalized for at least 2 nights in the past year
- Live in a nursing facility
- Have had 2 emergency room visits in the past year

Age Group

What is Involved?

If you choose to join this study, you will:
- Be randomized (like the flip of a coin) to get:
-- 3 doses of a study vaccine for the germ Clostridium difficile
-- 3 doses of a placebo (an inactive substance)
- Return for 5 outpatient visits to the Duke Early Phase Clinical Research Unit over the course of 7 month with a follow-up period for up to 3.5 years
- Have your blood drawn 3 times over 7 months

Study Details

Full Title
A Phase 3, Placebo-Controlled, Randomized, Observer-Blinded Study to Evaluate the Efficacy, Safety, and Tolerability of a Clostridium Difficile Vaccine in Adults 50 Years of Age and Older
Principal Investigator
Protocol Number
IRB: PRO00082496
NCT: NCT03090191
Phase III
Contact the Duke Recruitment Innovation Center